Turn on more accessible mode

Turn off more accessible mode

Skip Ribbon Commands

Skip to main content

Turn off Animations

Turn on Animations

Pharma RFP/Invitation Notices

Terms and Conditions:

All RFP proposals must be submitted through the Ariba sourcing tool.
Your company must be registered in Singapore to participate in ALPS events.
For all events, the Supply Head requirement for participation is EPU/DAP/32.
Each Company must participate at all sourcing events through or using the same Ariba account.

You can gain direct access into events by following the steps outlined below:

Click on the respective link found in the column “Respond to Posting”. You will be directed to the next page
Click on the “Respond to Posting” button found on the page
Log in to Ariba by entering your Ariba ID and password
You will gain access into the event for proposal submission
Submit your proposal in the Ariba sourcing tool before the closing date and time stated in the RFP notice below

Contact Persons:

Chua Chye Juan (Tel: 6377 8733)
Maimunah Abdul Rahman (Tel: 6377 8732)
Nor'ain Mohd Yusoff (Tel: 6377 8734)

Purchasing Programme

Evaluation Criteria

Evaluation Criteria (Unregistered Drugs)

RFP Results (Updated on 15 November 2019)

RFP/Invitation Notices

RFP No	Event Description	RFP Document	Published Date	Closing Date/time	Respond to Posting	Financial Category	Corrigendum	Remarks
GPOR 40119	Item 1 - Omeprazole 40mg Injection Item 2 - Pantoprazole 40mg Injection	GPOR 40119	15/11/2019	6/12/2019 12:00 PM	http://discovery.ariba.com/rfx/7530581	S5 or Higher	No
GPOR 40019	Item 1 - Esomeprazole 40mg Injection	GPOR 40019	15/11/2019	6/12/2019 12:00 PM	http://discovery.ariba.com/rfx/7530575	S3 or Higher	No
GPOR 39919	Item 1 - Aprepitant 80mg Capsules Item 2 - Aprepitant 125/80mg Tri-Capsule Pack Item 3 - Netupitant 300mg and Palonosetron 0.5mg Capsules	GPOR 39919	15/11/2019	6/12/2019 12:00 PM	http://discovery.ariba.com/rfx/7530560	S4 or Higher	No
GPOR 39819	Item 1 - Calfactant 105mg/3ml Intratracheal Suspension Item 2 - Calfactant 210mg/6ml Intratracheal Suspension	GPOR 39819	15/11/2019	6/12/2019 12:00 PM	http://discovery.ariba.com/rfx/7530539	S2 or Higher	No
GPOR 39719	Item 1 - Pentoxifylline 400mg Extended-Release Tablets	GPOR 39719	15/11/2019	6/12/2019 12:00 PM	http://discovery.ariba.com/rfx/7530519	S2 or Higher	No
GPOR 39619	Item 1 - Omalizumab 150mg Injection	GPOR 39619	15/11/2019	6/12/2019 12:00 PM	http://discovery.ariba.com/rfx/7530505	S2 or Higher	No
GPOR 39519	Item 1 - Epoprostenol for Injection, 1.5mg/vial	GPOR 39519	15/11/2019	6/12/2019 12:00 PM	http://discovery.ariba.com/rfx/7530490	S2 or Higher	No
GPOR 39419	Item 1 - Rituximab 100mg/10ml Injection Item 2 - Rituximab 500mg/50ml Injection Item 3 - Rituximab 1400mg/11.7ml Injection	GPOR 39419	08/11/2019	29/11/2019 12:00 PM	http://discovery.ariba.com/rfx/7439253	S8 or Higher	No
GPOR 39319	Item 1 - Alglucosidase Alfa for Injection, 50mg/vial	GPOR 39319	01/11/2019	22/11/2019 12:00 PM	http://discovery.ariba.com/rfx/7464317	S2 or Higher	No
GPOR 39219	Item 1 – Anti-D Blood Grouping Serum (RH 1), 10ml bottle	GPOR 39219	01/11/2019	22/11/2019 12:00 PM	http://discovery.ariba.com/rfx/7474396	S2 or Higher	No